AP NEWS

United States Spinal Muscular Atrophy Market and Competitive Landscape 2018: Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, and Market Shares - ResearchAndMarkets.com

October 5, 2018

DUBLIN--(BUSINESS WIRE)--Oct 5, 2018--The “US Spinal Muscular Atrophy Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

US Spinal Muscular Atrophy Market and Competitive Landscape - 2018, provides comprehensive insights into Spinal Muscular Atrophy pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Spinal Muscular Atrophy market size and drug sales. This research also provides insights into Spinal Muscular Atrophy epidemiology and late stage pipeline.

The research is classified into following sections - Spinal Muscular Atrophy overview with definitions, symptoms, etiology, diagnosis, treatment options; Spinal Muscular Atrophy pipeline insights covering late stage clinical trials pipeline; Spinal Muscular Atrophy prevalence trends by countries; Spinal Muscular Atrophy market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes the market - USA.

Research Scope:

Spinal Muscular Atrophy pipeline: Find out the drugs in clinical trials for Spinal Muscular Atrophy by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Spinal Muscular Atrophy epidemiology: Find out the prevalence of Spinal Muscular Atrophy in US; prevalence forecast to 2023 Spinal Muscular Atrophy products: Identify key products marketed and prescribed for Spinal Muscular Atrophy by brand name, by molecule, by company, by branded / generic, in US Spinal Muscular Atrophy market size: Find out the market size for Spinal Muscular Atrophy drugs in US; Find out how the market advanced from 2014 Spinal Muscular Atrophy drug sales: Find out the sales of Spinal Muscular Atrophy drugs in US Spinal Muscular Atrophy drugs sales forecast: Sales forecast for Spinal Muscular Atrophy drugs to 2023 in US Spinal Muscular Atrophy market share analysis: Find out the market shares of Spinal Muscular Atrophy drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/mbq2pr/united_states?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181005005409/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/05/2018 12:26 PM/DISC: 10/05/2018 12:28 PM

http://www.businesswire.com/news/home/20181005005409/en

AP RADIO
Update hourly